BRCA2 and cancer: Based on this observation, it is plausible that mutations in ALDH2, a gene coding for aldehyde dehydrogenase to detoxify acetaldehyde, may elevate cancer risk in individuals with a heterozygous BRCA2 truncating mutation such as the BRCA2 p.K3326* mutation.